ASO Author Reflections: SMARCA4 Deficiency as a Potential Biomarker for Adjuvant Therapy in Pulmonary Large Cell Carcinoma.

Saved in:
Bibliographic Details
Title: ASO Author Reflections: SMARCA4 Deficiency as a Potential Biomarker for Adjuvant Therapy in Pulmonary Large Cell Carcinoma.
Authors: Sun J; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China., Shen Z; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China., Han L; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China., Wan S; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China., Zhang P; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China., Song N; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China. songnan@tongji.edu.cn., Ye C; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China. sphyc1989@163.com.
Source: Annals of surgical oncology [Ann Surg Oncol] 2025 Sep; Vol. 32 (9), pp. 7095-7096. Date of Electronic Publication: 2025 Jun 04.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1534-4681
DOI:10.1245/s10434-025-17615-z